Differences in Sentinel lymph node biopsy outcomes and prognosis between HER2-low and HER2-zero breast cancer. Takada K, Kashiwagi S, Nishikawa M, Kochi A, et al. BMC Cancer 2025;25:1518.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takada K, Kashiwagi S, Nishikawa M, Kochi A, et al. Differences in Sentinel lymph node biopsy outcomes and prognosis between HER2-low and HER2-zero breast cancer. BMC Cancer 2025;25:1518.
PMID: 41053694